கிளாஸ் பேக்கர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
One to Watch Companies - Oncology, naxitamab, Ireland
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
One to Watch Companies - Oncology, Women s health, Sweden
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
One to Watch Companies - Oncology, Canada, Research
thepharmaletter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thepharmaletter.com Daily Mail and Mail on Sunday newspapers.
Updated results from phase 3 OCEAN study shows melflufen met primary endpoint of superior PFS - Overall Survival data lead to partial clinical hold
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Oncopeptides publishes report for Q1 2021 and updated dates for the publication of the reports for Q2 and Q3 2021
A strong start for PEPAXTO in the US
News provided by
Share this article
Share this article
STOCKHOLM, May 26, 2021 /PRNewswire/ Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has today published the report for the first quarter 2021. Oncopeptides now stands proudly among the few companies that have successfully navigated the long and difficult path from discovery to commercialization says CEO, Marty J Duvall.
Financial overview January-March
Operating loss amounted to SEK 347.3 M (loss: 296.9)